喘憋性肺炎多见于婴幼儿,6个月以内发病病情较重。病原学研究表明,此病由不同的病毒引起,呼吸道合胞病毒(RSV)是本病的主要病原,目前治疗无特效药物。我院1994年11月至1995年3月,应用胸腺肽及小剂量α—干扰素治疗喘憋性肺炎,取得显著疗效,现报告如下。 1 临床资料 1.1诊断际准:参照卫生部1987年小儿肺炎诊 Asthmatic pneumonia more common in infants and young children, onset of illness within 6 months heavier. Etiological studies have shown that the disease is caused by a different virus, respiratory syncytial virus (RSV) is the main pathogen of the disease, the current treatment of no specific drugs. Our hospital from November 1994 to March 1995, the application of thymosin and low-dose interferon alpha treatment of asthmatic pneumonia, and achieved significant results are as follows. 1 clinical data 1.1 diagnostic criteria: refer to the Ministry of Health 1987 Pediatric pneumonia clinic